Cargando…
Vaccine hesitancy and access to psoriasis care during the COVID‐19 pandemic: findings from a global patient‐reported cross‐sectional survey
Autores principales: | Bechman, Katie, Cook, Emma S., Dand, Nick, Yiu, Zenas Z.N., Tsakok, Teresa, Meynell, Freya, Coker, Bolaji, Vincent, Alexandra, Bachelez, Herve, Barbosa, Ines, Brown, Matthew A., Capon, Francesca, Contreras, Claudia R., De La Cruz, Claudia, Meglio, Paola Di, Gisondi, Paolo, Jullien, Denis, Kelly, Jade, Lambert, Jo, Lancelot, Camille, Langan, Sinead M., Mason, Kayleigh J., McAteer, Helen, Moorhead, Lucy, Naldi, Luigi, Norton, Sam, Puig, Lluís, Spuls, Phyllis I., Torres, Tiago, Urmston, Dominic, Vesty, Amber, Warren, Richard B., Waweru, Hoseah, Weinman, John, Griffiths, Christopher E.M., Barker, Jonathan N., Smith, Catherine H., Galloway, James B., Mahil, Satveer K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545500/ https://www.ncbi.nlm.nih.gov/pubmed/35104366 http://dx.doi.org/10.1111/bjd.21042 |
Ejemplares similares
-
Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study
por: Mahil, Satveer K., et al.
Publicado: (2021) -
Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey(*)
por: Mahil, S.K., et al.
Publicado: (2021) -
Psoriasis and Genetics
por: DAND, Nick, et al.
Publicado: (2020) -
Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab
por: Hanley, Tessa L, et al.
Publicado: (2017) -
Genetic Validation of Psoriasis Phenotyping in UK Biobank Supports the Utility of Self-Reported Data and Composite Definitions for Large Genetic and Epidemiological Studies
por: Saklatvala, Jake R., et al.
Publicado: (2023)